Lista de obras - Xavier Calvo - Dominio Público Uruguay

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

artículo científico publicado en 2018

Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia

artículo científico publicado en 2021

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms

scientific article published on 18 September 2020

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

scientific article published on 05 April 2020

Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group

artículo científico publicado en 2017

Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of p

artículo científico

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

artículo científico publicado en 2016

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.

artículo científico publicado en 2010

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation.

artículo científico publicado en 2011

Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

artículo científico publicado en 2017

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes

artículo científico publicado en 2016

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

artículo científico publicado en 2018

Excess mortality in the myelodysplastic syndromes.

artículo científico publicado en 2016

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

artículo científico publicado en 2010

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

artículo científico publicado en 2017

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.

artículo científico publicado en 2017

Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

artículo científico publicado en 2018

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA ⬇️

scientific article published on 01 May 2022

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features

artículo científico publicado en 2020

Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma

artículo científico publicado en 2018

Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.

artículo científico publicado en 2015

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.

artículo científico publicado en 2017

Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.

artículo científico

Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes

artículo científico publicado en 2015

Reply to M.A. Lichtman

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL

artículo científico publicado en 2018

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

artículo científico publicado en 2013

Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT.

artículo científico publicado en 2011

The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes

artículo científico publicado en 2019

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

artículo científico publicado en 2020

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma

artículo científico publicado en 2015

Lista de obras de Xavier Calvo

(In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes.

Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group

Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of p

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation.

Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Excess mortality in the myelodysplastic syndromes.

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.

Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA ⬇️

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features

Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma

Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.

Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.

Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes

Reply to M.A. Lichtman

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT.

The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma